Recombinant Human GRIN2A Protein，His

GRIN2A is a gene that encodes a subunit of the NMDA receptor, which plays a critical role in synaptic plasticity, learning, and memory formation in the central nervous system. Mutations and alterations in GRIN2A have been linked to various neurodevelopmental disorders, including epilepsy, intellectual disability, and autism spectrum disorders, making it a significant focus in neuroscience and genetic research. The study of GRIN2A is crucial not only for understanding the molecular mechanisms underlying these conditions but also for developing targeted therapies. Recombinant protein expression of GRIN2A can provide valuable insights into its functional properties and interactions, facilitating the investigation of its role in neuronal signaling pathways. Researchers utilize different expression systems to produce GRIN2A protein, enabling them to study its pharmacological characteristics, ligand binding, and structural dynamics. The detailed analysis of GRIN2A recombinant proteins holds promise for elucidating the pathophysiological mechanisms of related disorders and advancing therapeutic strategies aimed at modulating NMDA receptor activity. Understanding GRIN2A's structure and function can ultimately contribute to the development of innovative treatments for patients affected by GRIN2A-associated neurological disorders.